title: Orthotopic liver transplantation and renal function; outcome of hepatorenal syndrome and trial of verapamil for renal protection in nonhepatorenal syndrome.
authors: Department of Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246.
authors: T A
authors: TA
authors: Gonwa
authors: M
authors: M
authors: Goldstein
authors: M
authors: M
authors: Holman
authors: B S
authors: BS
authors: Husberg
authors: G B
authors: GB
authors: Klintmalm
mesh_terms: D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006530:Hepatorenal Syndrome / Q000601:surgery*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D015424:Reperfusion; D016019:Survival Analysis; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D016572:Cyclosporine; D003404:Creatinine; D014700:Verapamil